Differences between heart failure specialists and non-specialists regarding heart failure drug implementation and up-titration
- PMID: 37634943
- DOI: 10.1002/ejhf.3010
Differences between heart failure specialists and non-specialists regarding heart failure drug implementation and up-titration
References
-
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. https://doi.org/10.1002/ejhf.2333
-
- Fauvel C, Bonnet G, Mullens W, Giraldo CIS, Mežnar AZ, Barasa A, et al. Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: An international cardiology survey. Eur J Heart Fail 2023;25:213-222. https://doi.org/10.1002/ejhf.2743
-
- Metra M, Teerlink JR. Heart failure. Lancet 2017;390:1981-1995. https://doi.org/10.1016/S0140-6736(17)31071-1
-
- Marti CN, Fonarow GC, Anker SD, Yancy C, Vaduganathan M, Greene SJ, et al. Medication dosing for heart failure with reduced ejection fraction - Opportunities and challenges. Eur J Heart Fail 2019;21:286-296. https://doi.org/10.1002/ejhf.1351
-
- D'Amario D, Rodolico D, Rosano GMC, Dahlström U, Crea F, Lund LH, et al. Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: Data from the Swedish Heart Failure Registry. Eur J Heart Fail 2022;24:871-884. https://doi.org/10.1002/ejhf.2477